{"elements": {"nodes": [{"data": {"id": "HN", "label": "HN", "type": "oncology_category", "color": "#A9A9A9", "outline": "black"}, "classes": ""}, {"data": {"id": "Interventional_HN", "label": "Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Neoadjuvant Trials_Interventional_HN", "label": "Neoadjuvant Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Adjuvant Trials_Interventional_HN", "label": "Adjuvant Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Interventional_HN", "label": "Metastatic Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line1_Metastatic Trials_Interventional_HN", "label": "Line1", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "GS-1811", "label": "GS-1811", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "A Phase 1 Study to Evaluate the Safety Tolerability and Preliminary Efficacy of GS-1811 an Afucosylated Anti-CCR8 Monoclonal Antibody as Monotherapy and in Combination With an Anti\u2013PD-1 Monoclonal Antibody in Adults With Advanced Solid Tumors.", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/GS-1811%20(Gyn-Onc).aspx"}, "classes": "hidden"}, {"data": {"id": "Line2_Metastatic Trials_Interventional_HN", "label": "Line2", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "SGNDV-005 (Cohort 1)", "label": "SGNDV-005 (Cohort 1)", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "A Phase 2 Basket Study of Disitamab Vedotin in Adult Subjects with Previously Treated Locally-Advanced Unresectable or Metastatic Solid Tumors That Express HER2.", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/SGNDV-005%20(Cohort%201).aspx"}, "classes": "hidden"}, {"data": {"id": "ABBV-CLS-484", "label": "ABBV-CLS-484", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "A Phase 1 Study with ABBV-CLS-484 Alone and in Combination in Subjects with Locally Advanced or Metastatic Tumors.", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/ABBV-CLS-484-Alone-or-in-Combo-with-Pembro-or-Cabo.aspx"}, "classes": "hidden"}, {"data": {"id": "Line3+_Metastatic Trials_Interventional_HN", "label": "Line3+", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Non-Interventional_HN", "label": "Non-Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Breast", "label": "Breast", "type": "oncology_category", "color": "#A9A9A9", "outline": "black"}, "classes": ""}, {"data": {"id": "Interventional_Breast", "label": "Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Non-Interventional_Breast", "label": "Non-Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Postop/Adjuvant_Non-Interventional_Breast", "label": "Postop/Adjuvant", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "No Line_Postop/Adjuvant_Non-Interventional_Breast", "label": "No Line", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Oracle (Cohort 3)", "label": "Oracle (Cohort 3)", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "ORACLE: Observation of ResiduAl Cancer with Liquid Biopsy Evaluation.", "hyperlink": "https://365utsouthwestern.sharepoint.com/:u:/r/sites/MPOPClinicalTrials/SitePages/Following-ctDNA-Across-Multiple-Solid-Tumors-Using-Guardant-MRD-Assay-(Cohort-3).aspx"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Non-Interventional_Breast", "label": "Metastatic Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "No Line_Metastatic Trials_Non-Interventional_Breast", "label": "No Line", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "SIBYL", "label": "SIBYL", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "SIBYL: obServation of therapy response with lIquid BiopsY evaLuation.", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/SIBYL%20(GI).aspx"}, "classes": "hidden"}, {"data": {"id": "GI", "label": "GI", "type": "oncology_category", "color": "#A9A9A9", "outline": "black"}, "classes": ""}, {"data": {"id": "Interventional_GI", "label": "Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Neoadjuvant Trials_Interventional_GI", "label": "Neoadjuvant Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Adjuvant Trials_Interventional_GI", "label": "Adjuvant Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Interventional_GI", "label": "Metastatic Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line1_Metastatic Trials_Interventional_GI", "label": "Line1", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "XL092-002 (Cohort 7)", "label": "XL092-002 (Cohort 7)", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors.", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/XL092-combo-with-IO-Agents-in-first-line-nccRCC-and-HCC-(Cohort-7).aspx"}, "classes": "hidden"}, {"data": {"id": "Line2_Metastatic Trials_Interventional_GI", "label": "Line2", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line3+_Metastatic Trials_Interventional_GI", "label": "Line3+", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Non-Interventional_GI", "label": "Non-Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Postop/Adjuvant_Non-Interventional_GI", "label": "Postop/Adjuvant", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "No Line_Postop/Adjuvant_Non-Interventional_GI", "label": "No Line", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Oracle (Cohorts 5/6/7/12)", "label": "Oracle (Cohorts 5/6/7/12)", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "ORACLE: Observation of ResiduAl Cancer with Liquid Biopsy Evaluation.", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/Following-ctDNA-Across-Multiple-Solid-Tumors-Using-Guardant-MRD-Assay-(Cohort-5).aspx"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Non-Interventional_GI", "label": "Metastatic Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "No Line_Metastatic Trials_Non-Interventional_GI", "label": "No Line", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "GU", "label": "GU", "type": "oncology_category", "color": "#A9A9A9", "outline": "black"}, "classes": ""}, {"data": {"id": "Interventional_GU", "label": "Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Neoadjuvant Trials_Interventional_GU", "label": "Neoadjuvant Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Adjuvant Trials_Interventional_GU", "label": "Adjuvant Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Interventional_GU", "label": "Metastatic Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line1_Metastatic Trials_Interventional_GU", "label": "Line1", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "XL092-002 (Cohort 6)", "label": "XL092-002 (Cohort 6)", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors.", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/XL092-Combo-with-IO-Agents-in-First-Line-nccRCC-and-HCC.aspx"}, "classes": "hidden"}, {"data": {"id": "Line2_Metastatic Trials_Interventional_GU", "label": "Line2", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line3+_Metastatic Trials_Interventional_GU", "label": "Line3+", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Non-Interventional_GU", "label": "Non-Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Postop/Adjuvant_Non-Interventional_GU", "label": "Postop/Adjuvant", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "No Line_Postop/Adjuvant_Non-Interventional_GU", "label": "No Line", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Oracle (Cohorts 1/11)", "label": "Oracle (Cohorts 1/11)", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "ORACLE: Observation of ResiduAl Cancer with Liquid Biopsy Evaluation.", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/Following-ctDNA-Across-Multiple-Solid-Tumors-Using-Guardant-MRD-Assay.aspx"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Non-Interventional_GU", "label": "Metastatic Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Gyn/Onc", "label": "Gyn/Onc", "type": "oncology_category", "color": "#A9A9A9", "outline": "black"}, "classes": ""}, {"data": {"id": "Interventional_Gyn/Onc", "label": "Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Neoadjuvant Trials_Interventional_Gyn/Onc", "label": "Neoadjuvant Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Adjuvant Trials_Interventional_Gyn/Onc", "label": "Adjuvant Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Interventional_Gyn/Onc", "label": "Metastatic Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line1_Metastatic Trials_Interventional_Gyn/Onc", "label": "Line1", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line2_Metastatic Trials_Interventional_Gyn/Onc", "label": "Line2", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line3+_Metastatic Trials_Interventional_Gyn/Onc", "label": "Line3+", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Non-Interventional_Gyn/Onc", "label": "Non-Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Postop/Adjuvant_Non-Interventional_Gyn/Onc", "label": "Postop/Adjuvant", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "No Line_Postop/Adjuvant_Non-Interventional_Gyn/Onc", "label": "No Line", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Oracle (Cohorts 9/10)", "label": "Oracle (Cohorts 9/10)", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "ORACLE: Observation of ResiduAl Cancer with Liquid Biopsy Evaluation.", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/Following-ctDNA-Across-Multiple-Solid-Tumors-Using-Guardant-MRD-Assay-(Cohort-9-10).aspx"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Non-Interventional_Gyn/Onc", "label": "Metastatic Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Lung/Thoracic", "label": "Lung/Thoracic", "type": "oncology_category", "color": "#A9A9A9", "outline": "black"}, "classes": ""}, {"data": {"id": "Interventional_Lung/Thoracic", "label": "Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Non-Interventional_Lung/Thoracic", "label": "Non-Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Postop/Adjuvant_Non-Interventional_Lung/Thoracic", "label": "Postop/Adjuvant", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "No Line_Postop/Adjuvant_Non-Interventional_Lung/Thoracic", "label": "No Line", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Oracle (Cohort 2)", "label": "Oracle (Cohort 2)", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "ORACLE: Observation of ResiduAl Cancer with Liquid Biopsy Evaluation.", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/Following-ctDNA-Across-Multiple-Solid-Tumors-Using-Guardant-MRD-Assay-(Cohort-2).aspx"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Non-Interventional_Lung/Thoracic", "label": "Metastatic Trials", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Melanoma/Cutaneous/Sarcoma", "label": "Melanoma/Cutaneous/Sarcoma", "type": "oncology_category", "color": "#A9A9A9", "outline": "black"}, "classes": ""}, {"data": {"id": "Rad/Onc", "label": "Rad/Onc", "type": "oncology_category", "color": "#A9A9A9", "outline": "black"}, "classes": ""}, {"data": {"id": "Tumor Agnostic", "label": "Tumor Agnostic", "type": "oncology_category", "color": "#A9A9A9", "outline": "black"}, "classes": ""}, {"data": {"id": "Interventional_Tumor Agnostic", "label": "Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Non-Metastatic_Interventional_Tumor Agnostic", "label": "Non-Metastatic", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Metastatic_Interventional_Tumor Agnostic", "label": "Metastatic", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "No Line_Metastatic_Interventional_Tumor Agnostic", "label": "No Line", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "NCI AIM NIVO", "label": "NCI AIM NIVO", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "A Phase 1b Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO).", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/Nivo-for-Autoimmune-Disorders-and-Advanced-Malignancies.aspx"}, "classes": "hidden"}, {"data": {"id": "LOXO-Libretto-001", "label": "LOXO-Libretto-001", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "A Phase 1/2 Study of Oral Selpercatinib (LOXO-292) in Patients with Advanced Solid Tumors Including RET Fusion-Positive Solid Tumors Medullary Thyroid Cancer and Other Tumors with RET Activation (LIBRETTO-001).", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/Selpercatinib-in-Ret-fusion-Positive-Solid-Tumors.aspx"}, "classes": "hidden"}, {"data": {"id": "Other_Interventional_Tumor Agnostic", "label": "Other", "type": "trial_phase", "color": "#ADD8E6", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "No Line_Other_Interventional_Tumor Agnostic", "label": "No Line", "type": "therapy_line", "color": "#90EE90", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "SWOG 2012", "label": "SWOG 2012", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "Randomized Phase II/III Trial Of First Line Platinum/Etoposide With Or Without Atezolizumab (Nsc#783608) In Patients With Advanced Or Metastatic Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas (NEC).", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/First-Line-Platinum-Etoposide-with-or-without-Atezolizumab-for-Neuroendocrine-Carcinoma.aspx"}, "classes": "hidden"}, {"data": {"id": "Atrium", "label": "Atrium", "type": "trial_code", "color": "#FFA07A", "outline": "black", "description": "A Phase 3 Investigator-Initiated Randomized Double- Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Compared to Placebo in Hospitalized Participants with Immune Checkpoint Inhibitor Associated Myocarditis.", "hyperlink": "https://365utsouthwestern.sharepoint.com/sites/MPOPClinicalTrials/SitePages/AbatacepT-foR-ImmUne-checkpoint-inhibitor-associated-Myocarditis-(ATRIUM).aspx"}, "classes": "hidden"}, {"data": {"id": "Non-Interventional_Tumor Agnostic", "label": "Non-Interventional", "type": "study_type", "color": "#D2B48C", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Neoadjuvant Trials_Interventional_HN_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Adjuvant Trials_Interventional_HN_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Non-Interventional_HN_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Interventional_Breast_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Neoadjuvant Trials_Interventional_GI_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Adjuvant Trials_Interventional_GI_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line2_Metastatic Trials_Interventional_GI_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line3+_Metastatic Trials_Interventional_GI_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Neoadjuvant Trials_Interventional_GU_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Adjuvant Trials_Interventional_GU_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line2_Metastatic Trials_Interventional_GU_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line3+_Metastatic Trials_Interventional_GU_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Non-Interventional_GU_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Neoadjuvant Trials_Interventional_Gyn/Onc_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Adjuvant Trials_Interventional_Gyn/Onc_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line1_Metastatic Trials_Interventional_Gyn/Onc_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Line2_Metastatic Trials_Interventional_Gyn/Onc_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Non-Interventional_Gyn/Onc_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Interventional_Lung/Thoracic_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Metastatic Trials_Non-Interventional_Lung/Thoracic_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Melanoma/Cutaneous/Sarcoma_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Rad/Onc_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Non-Metastatic_Interventional_Tumor Agnostic_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}, {"data": {"id": "Non-Interventional_Tumor Agnostic_no_trials", "label": "No Trials", "type": "no_trials", "color": "#FFFF00", "outline": "black"}, "classes": "hidden"}], "edges": [{"data": {"source": "HN", "target": "Interventional_HN", "arrow": true}, "classes": "hidden"}, {"data": {"source": "HN", "target": "Non-Interventional_HN", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_HN", "target": "Neoadjuvant Trials_Interventional_HN", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_HN", "target": "Adjuvant Trials_Interventional_HN", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_HN", "target": "Metastatic Trials_Interventional_HN", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Neoadjuvant Trials_Interventional_HN", "target": "Neoadjuvant Trials_Interventional_HN_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Adjuvant Trials_Interventional_HN", "target": "Adjuvant Trials_Interventional_HN_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_HN", "target": "Line1_Metastatic Trials_Interventional_HN", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_HN", "target": "Line2_Metastatic Trials_Interventional_HN", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_HN", "target": "Line3+_Metastatic Trials_Interventional_HN", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line1_Metastatic Trials_Interventional_HN", "target": "GS-1811", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line2_Metastatic Trials_Interventional_HN", "target": "SGNDV-005 (Cohort 1)", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line2_Metastatic Trials_Interventional_HN", "target": "ABBV-CLS-484", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line3+_Metastatic Trials_Interventional_HN", "target": "ABBV-CLS-484", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_HN", "target": "Non-Interventional_HN_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Breast", "target": "Interventional_Breast", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Breast", "target": "Non-Interventional_Breast", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_Breast", "target": "Interventional_Breast_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_Breast", "target": "Postop/Adjuvant_Non-Interventional_Breast", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_Breast", "target": "Metastatic Trials_Non-Interventional_Breast", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Postop/Adjuvant_Non-Interventional_Breast", "target": "No Line_Postop/Adjuvant_Non-Interventional_Breast", "arrow": true}, "classes": "hidden"}, {"data": {"source": "No Line_Postop/Adjuvant_Non-Interventional_Breast", "target": "Oracle (Cohort 3)", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Non-Interventional_Breast", "target": "No Line_Metastatic Trials_Non-Interventional_Breast", "arrow": true}, "classes": "hidden"}, {"data": {"source": "No Line_Metastatic Trials_Non-Interventional_Breast", "target": "SIBYL", "arrow": true}, "classes": "hidden"}, {"data": {"source": "GI", "target": "Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "GI", "target": "Non-Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_GI", "target": "Neoadjuvant Trials_Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_GI", "target": "Adjuvant Trials_Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_GI", "target": "Metastatic Trials_Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Neoadjuvant Trials_Interventional_GI", "target": "Neoadjuvant Trials_Interventional_GI_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Adjuvant Trials_Interventional_GI", "target": "Adjuvant Trials_Interventional_GI_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_GI", "target": "Line1_Metastatic Trials_Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_GI", "target": "Line2_Metastatic Trials_Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_GI", "target": "Line3+_Metastatic Trials_Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line1_Metastatic Trials_Interventional_GI", "target": "XL092-002 (Cohort 7)", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line2_Metastatic Trials_Interventional_GI", "target": "Line2_Metastatic Trials_Interventional_GI_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line3+_Metastatic Trials_Interventional_GI", "target": "Line3+_Metastatic Trials_Interventional_GI_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_GI", "target": "Postop/Adjuvant_Non-Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_GI", "target": "Metastatic Trials_Non-Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Postop/Adjuvant_Non-Interventional_GI", "target": "No Line_Postop/Adjuvant_Non-Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "No Line_Postop/Adjuvant_Non-Interventional_GI", "target": "Oracle (Cohorts 5/6/7/12)", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Non-Interventional_GI", "target": "No Line_Metastatic Trials_Non-Interventional_GI", "arrow": true}, "classes": "hidden"}, {"data": {"source": "No Line_Metastatic Trials_Non-Interventional_GI", "target": "SIBYL", "arrow": true}, "classes": "hidden"}, {"data": {"source": "GU", "target": "Interventional_GU", "arrow": true}, "classes": "hidden"}, {"data": {"source": "GU", "target": "Non-Interventional_GU", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_GU", "target": "Neoadjuvant Trials_Interventional_GU", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_GU", "target": "Adjuvant Trials_Interventional_GU", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_GU", "target": "Metastatic Trials_Interventional_GU", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Neoadjuvant Trials_Interventional_GU", "target": "Neoadjuvant Trials_Interventional_GU_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Adjuvant Trials_Interventional_GU", "target": "Adjuvant Trials_Interventional_GU_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_GU", "target": "Line1_Metastatic Trials_Interventional_GU", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_GU", "target": "Line2_Metastatic Trials_Interventional_GU", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_GU", "target": "Line3+_Metastatic Trials_Interventional_GU", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line1_Metastatic Trials_Interventional_GU", "target": "XL092-002 (Cohort 6)", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line2_Metastatic Trials_Interventional_GU", "target": "Line2_Metastatic Trials_Interventional_GU_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line3+_Metastatic Trials_Interventional_GU", "target": "Line3+_Metastatic Trials_Interventional_GU_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_GU", "target": "Postop/Adjuvant_Non-Interventional_GU", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_GU", "target": "Metastatic Trials_Non-Interventional_GU", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Postop/Adjuvant_Non-Interventional_GU", "target": "No Line_Postop/Adjuvant_Non-Interventional_GU", "arrow": true}, "classes": "hidden"}, {"data": {"source": "No Line_Postop/Adjuvant_Non-Interventional_GU", "target": "Oracle (Cohorts 1/11)", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Non-Interventional_GU", "target": "Metastatic Trials_Non-Interventional_GU_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Gyn/Onc", "target": "Interventional_Gyn/Onc", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Gyn/Onc", "target": "Non-Interventional_Gyn/Onc", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_Gyn/Onc", "target": "Neoadjuvant Trials_Interventional_Gyn/Onc", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_Gyn/Onc", "target": "Adjuvant Trials_Interventional_Gyn/Onc", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_Gyn/Onc", "target": "Metastatic Trials_Interventional_Gyn/Onc", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Neoadjuvant Trials_Interventional_Gyn/Onc", "target": "Neoadjuvant Trials_Interventional_Gyn/Onc_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Adjuvant Trials_Interventional_Gyn/Onc", "target": "Adjuvant Trials_Interventional_Gyn/Onc_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_Gyn/Onc", "target": "Line1_Metastatic Trials_Interventional_Gyn/Onc", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_Gyn/Onc", "target": "Line2_Metastatic Trials_Interventional_Gyn/Onc", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Interventional_Gyn/Onc", "target": "Line3+_Metastatic Trials_Interventional_Gyn/Onc", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line1_Metastatic Trials_Interventional_Gyn/Onc", "target": "Line1_Metastatic Trials_Interventional_Gyn/Onc_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line2_Metastatic Trials_Interventional_Gyn/Onc", "target": "Line2_Metastatic Trials_Interventional_Gyn/Onc_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Line3+_Metastatic Trials_Interventional_Gyn/Onc", "target": "GS-1811", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_Gyn/Onc", "target": "Postop/Adjuvant_Non-Interventional_Gyn/Onc", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_Gyn/Onc", "target": "Metastatic Trials_Non-Interventional_Gyn/Onc", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Postop/Adjuvant_Non-Interventional_Gyn/Onc", "target": "No Line_Postop/Adjuvant_Non-Interventional_Gyn/Onc", "arrow": true}, "classes": "hidden"}, {"data": {"source": "No Line_Postop/Adjuvant_Non-Interventional_Gyn/Onc", "target": "Oracle (Cohorts 9/10)", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Non-Interventional_Gyn/Onc", "target": "Metastatic Trials_Non-Interventional_Gyn/Onc_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Lung/Thoracic", "target": "Interventional_Lung/Thoracic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Lung/Thoracic", "target": "Non-Interventional_Lung/Thoracic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_Lung/Thoracic", "target": "Interventional_Lung/Thoracic_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_Lung/Thoracic", "target": "Postop/Adjuvant_Non-Interventional_Lung/Thoracic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_Lung/Thoracic", "target": "Metastatic Trials_Non-Interventional_Lung/Thoracic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Postop/Adjuvant_Non-Interventional_Lung/Thoracic", "target": "No Line_Postop/Adjuvant_Non-Interventional_Lung/Thoracic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "No Line_Postop/Adjuvant_Non-Interventional_Lung/Thoracic", "target": "Oracle (Cohort 2)", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic Trials_Non-Interventional_Lung/Thoracic", "target": "Metastatic Trials_Non-Interventional_Lung/Thoracic_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Melanoma/Cutaneous/Sarcoma", "target": "Melanoma/Cutaneous/Sarcoma_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Rad/Onc", "target": "Rad/Onc_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Tumor Agnostic", "target": "Interventional_Tumor Agnostic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Tumor Agnostic", "target": "Non-Interventional_Tumor Agnostic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_Tumor Agnostic", "target": "Non-Metastatic_Interventional_Tumor Agnostic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_Tumor Agnostic", "target": "Metastatic_Interventional_Tumor Agnostic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Interventional_Tumor Agnostic", "target": "Other_Interventional_Tumor Agnostic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Metastatic_Interventional_Tumor Agnostic", "target": "Non-Metastatic_Interventional_Tumor Agnostic_no_trials", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Metastatic_Interventional_Tumor Agnostic", "target": "No Line_Metastatic_Interventional_Tumor Agnostic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "No Line_Metastatic_Interventional_Tumor Agnostic", "target": "NCI AIM NIVO", "arrow": true}, "classes": "hidden"}, {"data": {"source": "No Line_Metastatic_Interventional_Tumor Agnostic", "target": "LOXO-Libretto-001", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Other_Interventional_Tumor Agnostic", "target": "No Line_Other_Interventional_Tumor Agnostic", "arrow": true}, "classes": "hidden"}, {"data": {"source": "No Line_Other_Interventional_Tumor Agnostic", "target": "SWOG 2012", "arrow": true}, "classes": "hidden"}, {"data": {"source": "No Line_Other_Interventional_Tumor Agnostic", "target": "Atrium", "arrow": true}, "classes": "hidden"}, {"data": {"source": "Non-Interventional_Tumor Agnostic", "target": "Non-Interventional_Tumor Agnostic_no_trials", "arrow": true}, "classes": "hidden"}]}}